Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Incidence of symptomatic congestive heart failure\n(CHF) using New York Heart Association class II, III and IV, and cardiac death

Outcome Time Frame:

On treatment and up to 5 years follow-up

Safety Issue:

Yes

Principal Investigator

Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

Hoffmann-La Roche

Authority:

Germany: Federal Institute for Drigs and Medical Devices

Study ID:

BO20652

NCT ID:

NCT01152606

Start Date:

August 2007

Completion Date:

April 2016

Related Keywords:

• Breast Cancer
• Breast Neoplasms